Jason Kelly, Ginkgo Bioworks CEO
Ginkgo joins Esperovax to attempt RNA cancer treatment — in a pill
Ginkgo Bioworks and Esperovax are collaborating on making an RNA pill to treat colorectal cancers, the duo announced Thursday.
The science is still in early …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.